Nguyen, A. et al. Developments in drug overdose deaths by intent and drug classes, United States, 1999‒2022. Am. J. Public Well being. 114, 1081–1085 (2024).
Langabeer, J. R. et al. Prevalence and expenses of opioid-related visits to US emergency departments. Drug Alcohol Rely. 221, 108568 (2021).
Drug Abuse Warning Community (DAWN): findings from drug-related emergency division visits, CBHSQ information. Accessed 24 September 2024. https://www.samhsa.gov/information/report/2022-findings-drug-related-emergency-department-visits (2022).
King, C., Prepare dinner, R., Korthuis, P. T., Morris, C. D. & Englander, H. Causes of loss of life within the 12 months after hospital discharge amongst sufferers with opioid use dysfunction. J. Addict. Med. 16, 466–469 (2022).
Englander, H. & Davis, C. S. Hospital requirements of look after individuals with substance use dysfunction. N. Engl. J. Med. 387, 672–675 (2022).
Nordeck, C. D. et al. Opioid agonist therapy initiation and linkage for hospitalized sufferers seen by a substance use dysfunction session service. Drug Alcohol Rely. Rep. 2, 100031 (2022).
Calcaterra, S. L. et al. Administration of opioid use dysfunction and related circumstances amongst hospitalized adults: a consensus assertion from the Society of Hospital Medication. J. Hosp. Med. 17, 744–756 (2022).
Moyo, P. et al. Discharge areas after hospitalizations involving opioid use dysfunction amongst medicare beneficiaries. Addict. Sci. Clin. Pract. 17, 57 (2022).
Wakeman, S. E., Metlay, J. P., Chang, Y., Herman, G. E. & Rigotti, N. A. Inpatient dependancy session for hospitalized sufferers will increase post-discharge abstinence and reduces dependancy severity. J. Gen. Intern. Med. 32, 909–916 (2017).
Englander, H. et al. ‘We’ve discovered it’s a medical sickness, not an ethical selection’: qualitative examine of the consequences of a multicomponent dependancy intervention on hospital suppliers’ attitudes and experiences. J. Hosp. Med. 13, 752–758 (2018).
Hoover, Okay., Lockhart, S., Callister, C., Holtrop, J. S. & Calcaterra, S. L. Experiences of stigma in hospitals with dependancy session providers: a qualitative evaluation of sufferers’ and hospital-based suppliers’ views. J. Subst. Abuse Deal with. 138, 108708 (2022).
Callister, C., Lockhart, S., Holtrop, J. S., Hoover, Okay. & Calcaterra, S. L. Experiences with an dependancy session service on care offered to hospitalized sufferers with opioid use dysfunction: a qualitative examine of hospitalists, nurses, pharmacists, and social staff. Subst. Abus. 43, 615–622 (2022).
Wilson, J. D. et al. Inpatient dependancy drugs session service impression on post-discharge affected person mortality: a propensity-matched evaluation. J. Gen. Intern. Med. 37, 2521–2525 (2022).
Englander, H. et al. Caring for hospitalized adults with opioid use dysfunction within the period of fentanyl: a evaluation. JAMA Intern. Med. 184, 691–701 (2024).
Khan, M. et al. ‘Earlier than medically suggested’ departure from hospital and subsequent drug overdose: a population-based cohort examine. CMAJ 196, E1066–E1075 (2024).
McNeely, J. et al. Habit session providers for opioid use dysfunction therapy initiation and engagement: a randomized medical trial. JAMA Intern. Med. 184, 1106–1115 (2024).
Serowik, Okay. L. et al. Substance use dysfunction detection charges amongst suppliers of common medical inpatients. J. Gen. Intern. Med. 36, 668–675 (2021).
McNeely, J. et al. Efficiency of the tobacco, alcohol, prescription medicine, and different substance use (TAPS) software for substance use screening in major care sufferers. Ann. Intern. Med. 16, 690–699 (2016).
McNeely, J. et al. A quick affected person self-administered substance use screening software for major care: two-site validation examine of the substance use temporary display screen (SUBS). Am. J. Med. 128, e9–e19 (2015).
Yudko, E., Lozhkina, O. & Fouts, A. A complete evaluation of the psychometric properties of the Drug Abuse Screening Check. J. Subst. Abuse Deal with. 32, 89–198 (2007).
Vasey, B. et al. Reporting guideline for the early stage medical analysis of choice help methods pushed by synthetic intelligence: DECIDE-AI. BMJ 377, e070904 (2022).
Afshar, M. et al. Subtypes in sufferers with opioid misuse: a prognostic enrichment technique utilizing digital well being file information in hospitalized sufferers. PLoS ONE 14, e0219717 (2019).
Sharma, B. et al. Publicly obtainable machine studying fashions for figuring out opioid misuse from the medical notes of hospitalized sufferers. BMC. Med. Inform. Decis. Mak. 20, 79 (2020).
Afshar, M. et al. Exterior validation of an opioid misuse machine studying classifier in hospitalized grownup sufferers. Addict. Sci. Clin. Pract. 16, 19 (2021).
Thompson, H. M. et al. Bias and equity evaluation of a pure language processing opioid misuse classifier: detection and mitigation of digital well being file information disadvantages throughout racial subgroups. J. Am. Med. Inform. Assoc. 28, 2393–2403 (2021).
Afshar, M. et al. Improvement and multimodal validation of a substance misuse algorithm for referral to therapy utilizing synthetic intelligence (SMART-AI): a retrospective deep studying examine. Lancet Digit. Well being. 4, e426–e435 (2022).
Afshar, M. et al. Deployment of real-time pure language processing and deep studying medical choice help within the digital well being file: pipeline implementation for an opioid misuse screener in hospitalized adults. JMIR Med. Inform. 11, e44977 (2023).
Damschroder, L. J. et al. Fostering implementation of well being providers analysis findings into follow: a consolidated framework for advancing implementation science. Implement. Sci. 4, 50 (2009).
Powell, B. J. et al. A refined compilation of implementation methods: outcomes from the Professional Suggestions for Implementing Change (ERIC) mission. Implement. Sci. 10, 21 (2015).
Ahmed, M. I. et al. A scientific evaluation of the boundaries to the implementation of synthetic intelligence in healthcare. Cureus 15, e46454 (2023).
Wan, P. et al. Outpatient reception by way of collaboration between nurses and a big language mannequin: a randomized managed trial. Nat. Med. 30, 2878–2885 (2024).
Liao, F., Adelaine, S., Afshar, M. & Patterson, B. W. Governance of medical AI purposes to facilitate secure and equitable deployment in a big well being system: key components and early successes. Entrance. Digit. Well being 4, 931439 (2022).
Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M. & Stetler, C. Effectiveness-implementation hybrid designs: combining components of medical effectiveness and implementation analysis to boost public well being impression. Medical Care 50, 217–226 (2012).
Ullman, A. J., Beidas, R. S. & Bonafide, C. P. Methodological progress observe: hybrid effectiveness‐implementation medical trials. J. Hosp. Med. 17, 912–916 (2022).
Alemu, B. T., Olayinka, O. & Martin, B. C. Traits of hospitalized adults with opioid use dysfunction in america: nationwide inpatient pattern. Ache Doctor 24, 327–334 (2021).
Lo-Ciganic, W.-H. et al. Analysis of machine-learning algorithms for predicting opioid overdose threat amongst medicare beneficiaries with opioid prescriptions. JAMA Netw. Open. 2, e190968 (2019).
Wynants, L. et al. Prediction fashions for analysis and prognosis of COVID-19: systematic evaluation and important appraisal. BMJ 369, m1328 (2020).
Carayon, P. et al. Software of human elements to enhance usability of medical choice help for diagnostic decision-making: a scenario-based simulation examine. BMJ Qual. Saf. 29, 329–340 (2020).
Schwartz, J. M. et al. Components influencing clinician belief in predictive medical choice help methods for in-hospital deterioration: qualitative descriptive examine. JMIR Hum. Components. 9, e33960 (2022).
Chaparro, J. D. et al. Lowering interruptive alert burden utilizing high quality enchancment methodology. Appl. Clin. Inform. 11, 46–58 (2020).
Weiner, S. G. et al. Opioid overdose after medicine for opioid use dysfunction initiation following hospitalization or ED go to. JAMA Netw. Open. 7, e2423954 (2024).
James, H., Morgan, J., Ti, L. & Nolan, S. Transitions in care between hospital and group settings for people with a substance use dysfunction: a scientific evaluation. Drug Alcohol Rely. 243, 109763 (2023).
Company for Healthcare Analysis and High quality (AHRQ), Healthcare Value and Utilization Venture (HCUP), Nationwide Readmissions Database (NRD). Traits of 30-Day All-Trigger Hospital Readmissions, 2016–2020. Accessed 24 September 2024. https://hcup-us.ahrq.gov/reviews/statbriefs/sb304-readmissions-2016-2020.jsp (2024).
Cano, M. & Sparks, C. S. Drug overdose mortality by race/ethnicity throughout US-born and immigrant populations. Drug Alcohol Rely. 232, 109309 (2022).
Magee, T. et al. Inequities within the therapy of opioid use dysfunction: a scoping evaluation. J. Subst. Use Addict. Deal with. 152, 209082 (2023).
Nguyen, T. et al. Racial and ethnic disparities in buprenorphine and extended-release naltrexone stuffed prescriptions through the COVID-19 pandemic. JAMA Netw. Open 5, e2214765 (2022).
Barocas, J. A. et al. Medical impression, prices, and cost-effectiveness of hospital-based methods for addressing the US opioid epidemic: a modelling examine. Lancet Public Well being 7, e56–e64 (2022).
Fairley, M. et al. Value-effectiveness of remedies for opioid use dysfunction. JAMA Psychiatry 78, 767–777 (2021).
Chen, H. et al. Facilitation or hindrance: physicians’ notion on Greatest Observe Alerts (BPA) utilization in an digital well being file system. Well being Commun. 34, 942–948 (2019).
Orenstein, E. W. et al. Alert burden in pediatric hospitals: a cross-sectional evaluation of six tutorial pediatric well being methods utilizing novel metrics. J. Am. Med. Inform. Assoc. 28, 2654–2660 (2021).
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. Okay. & SPIRIT-AI and CONSORT-AI Working Group. Reporting tips for medical trial reviews for interventions involving synthetic intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364–1374 (2020).
Bradley, Okay. A. et al. AUDIT-C as a short display screen for alcohol misuse in major care. Alcohol Clin. Exp. Res. 31, 1208–1217 (2007).
Vavalle, J. P. et al. Hospital size of keep in sufferers with non-ST-segment elevation myocardial infarction. Am. J. Med. 125, 1085–1094 (2012).
Sundararajan, M., Taly, A. & Yan, Q. Axiomatic attribution for deep networks. In Proc. thirty fourth Worldwide Convention on Machine Studying (eds Precup, D. & Teh, Y. W.) Vol. 70, 3319–3328 (PMLR, 2017).
Zuckerman, R. B., Sheingold, S. H., Orav, E. J., Ruhter, J. & Epstein, A. M. Readmissions, commentary, and the hospital readmissions discount program. N. Engl. J. Med. 374, 1543–1551 (2016).
Sheehy, A. M. et al. The hospital readmissions discount program and commentary hospitalizations. J. Hosp. Med. 16, 409–411 (2021).
Elixhauser, A., Steiner, C., Harris, D. R. & Coffey, R. M. Comorbidity measures to be used with administrative information. Med. Care 36, 8–27 (1998).
